RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Acute Liver Failure |
|
Accession: | DOID:9004590
|
browse the term
|
Definition: | A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C. |
Synonyms: | exact_synonym: | Acute Hepatic Failure; Fulminant Hepatic Failure; Fulminant Hepatic Failures; Fulminant Liver Failure; Fulminant Liver Failures; Fulminating Hepatic Failure; Fulminating Hepatic Failures; Fulminating Liver Failure; Fulminating Liver Failures; acute liver injury |
| narrow_synonym: | Recurrent Acute Liver Failure |
| primary_id: | MESH:D017114 |
| alt_id: | RDO:0000601 |
|
|
Please select species to view GViewer data.
|
|
G |
N |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chrNW_004624737:11,593,701...11,686,790
Ensembl chrNW_004624737:11,593,864...11,688,460
|
|
G |
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
|
|
G |
P |
ABCC2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,633...111,037,537
|
|
G |
S |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chrNW_004936636:292,631...341,999
Ensembl chrNW_004936636:292,709...340,393
|
|
G |
D |
ABCC2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chr28:12,670,885...12,740,124
Ensembl chr28:12,670,885...12,740,740
|
|
G |
B |
ABCC2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chr10:96,385,534...96,458,571
Ensembl chr10:99,889,160...99,947,270
|
|
G |
C |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
|
|
G |
R |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
IEP |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
M |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
H |
ABCC2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
|
RGD |
PMID:16899240 |
RGD:1598605 |
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
treatment |
ISO |
associated with Chronic Hepatitis B |
RGD |
PMID:22321886 |
RGD:39938835 |
NCBI chr12:4,863,100...4,892,204
Ensembl chr12:4,863,165...4,885,849
|
|
G |
P |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
treatment |
ISO |
associated with Chronic Hepatitis B |
RGD |
PMID:22321886 |
RGD:39938835 |
NCBI chr 1:272,912,239...272,935,316
|
|
G |
S |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
treatment |
ISO |
associated with Chronic Hepatitis B |
RGD |
PMID:22321886 |
RGD:39938835 |
NCBI chrNW_004936570:1,315,192...1,322,719
|
|
G |
D |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
treatment |
ISO |
associated with Chronic Hepatitis B |
RGD |
PMID:22321886 |
RGD:39938835 |
NCBI chr 9:49,746,749...49,758,317
Ensembl chr 9:49,748,693...49,758,479
|
|
G |
B |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
treatment |
ISO |
associated with Chronic Hepatitis B |
RGD |
PMID:22321886 |
RGD:39938835 |
NCBI chr 9:104,354,115...104,399,057
Ensembl chr 9:132,989,574...133,010,324
|
|
G |
R |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
treatment |
ISO |
associated with Chronic Hepatitis B |
RGD |
PMID:22321886 |
RGD:39938835 |
NCBI chr 3:10,162,087...10,182,835
Ensembl chr 3:10,162,096...10,191,423
|
|
G |
M |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
treatment |
ISO |
associated with Chronic Hepatitis B |
RGD |
PMID:22321886 |
RGD:39938835 |
NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991
|
|
G |
H |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
treatment |
IEP |
associated with Chronic Hepatitis B |
RGD |
PMID:22321886 |
RGD:39938835 |
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
|
|
G |
H |
ADH1A |
alcohol dehydrogenase 1A (class I), alpha polypeptide |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 4:99,276,369...99,290,985
Ensembl chr 4:99,276,369...99,291,003
|
|
G |
B |
ADH1B |
alcohol dehydrogenase 1B (class I), beta polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 4:91,726,870...91,741,824
Ensembl chr 4:102,388,575...102,435,079
|
|
G |
H |
ADH1B |
alcohol dehydrogenase 1B (class I), beta polypeptide |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401
|
|
G |
N |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chrNW_004624735:34,105,237...34,123,479
Ensembl chrNW_004624735:34,104,537...34,123,624
|
|
G |
G |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
|
|
G |
P |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
|
|
G |
D |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
|
|
G |
B |
ALB |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
|
|
G |
C |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chrNW_004955447:9,327...21,212
|
|
G |
R |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
M |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
H |
ALB |
albumin |
|
EXP |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:16750869 PMID:18609519 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
N |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624781:4,365,378...4,477,004
Ensembl chrNW_004624781:4,441,238...4,477,004
|
|
G |
G |
ANP32A |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr26:14,650,600...14,691,108
Ensembl chr26:14,653,745...14,691,492
|
|
G |
P |
ANP32A |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:166,664,251...166,703,814
|
|
G |
S |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936471:28,601,816...28,635,002
|
|
G |
D |
ANP32A |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr30:32,741,582...32,778,883
Ensembl chr30:32,741,582...32,798,188
|
|
G |
B |
ANP32A |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr15:47,736,770...47,778,763
Ensembl chr15:66,502,285...66,511,637
|
|
G |
C |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955450:7,449,368...7,484,524
|
|
G |
R |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
M |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:62,248,637...62,286,084
Ensembl chr 9:62,248,575...62,286,094
|
|
G |
H |
ANP32A |
acidic nuclear phosphoprotein 32 family member A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr15:68,778,535...68,820,895
Ensembl chr15:68,778,535...68,820,897
|
|
G |
N |
Apoc2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624907:1,765,467...1,769,786
Ensembl chrNW_004624907:1,765,481...1,769,781
|
|
G |
G |
APOC2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 6:38,406,829...38,411,239
Ensembl chr 6:38,409,641...38,410,927
|
|
G |
P |
APOC2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 6:51,404,219...51,406,302
|
|
G |
S |
Apoc2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936706:1,531,219...1,531,921
|
|
G |
D |
APOC2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:110,504,806...110,506,986
Ensembl chr 1:110,504,815...110,506,961
|
|
G |
B |
APOC2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr19:41,892,954...41,896,461
|
|
G |
C |
Apoc2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955555:2,019,547...2,021,543
Ensembl chrNW_004955555:2,016,217...2,021,830
|
|
G |
R |
Apoc2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
M |
Apoc2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866
|
|
G |
H |
APOC2 |
apolipoprotein C2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
|
|
G |
N |
Ass1 |
argininosuccinate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624760:5,180,095...5,221,677
Ensembl chrNW_004624760:5,180,095...5,221,732
|
|
G |
G |
ASS1 |
argininosuccinate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr12:7,643,484...7,701,334
|
|
G |
P |
ASS1 |
argininosuccinate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:270,531,434...270,586,364
Ensembl chr 1:270,531,589...270,586,364
|
|
G |
S |
Ass1 |
argininosuccinate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936487:17,482,307...17,527,407
Ensembl chrNW_004936487:17,486,826...17,527,435
|
|
G |
D |
ASS1 |
argininosuccinate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:53,425,228...53,478,007
Ensembl chr 9:53,425,448...53,477,904
|
|
G |
B |
ASS1 |
argininosuccinate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:101,569,442...101,625,899
Ensembl chr 9:130,219,993...130,276,036
|
|
G |
C |
Ass1 |
argininosuccinate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955513:443,372...485,190
Ensembl chrNW_004955513:445,462...485,190
|
|
G |
R |
Ass1 |
argininosuccinate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
M |
Ass1 |
argininosuccinate synthetase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
|
|
G |
H |
ASS1 |
argininosuccinate synthase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
|
|
G |
N |
Atm |
ATM serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:21224054 PMID:24565947 |
RGD:10053604 RGD:10053606 |
NCBI chrNW_004624784:2,933,172...3,080,131
Ensembl chrNW_004624784:2,937,499...3,078,216
|
|
G |
G |
ATM |
ATM serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:21224054 PMID:24565947 |
RGD:10053604 RGD:10053606 |
NCBI chr 1:99,653,208...99,786,889
Ensembl chr 1:99,653,139...99,791,520
|
|
G |
P |
ATM |
ATM serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:21224054 PMID:24565947 |
RGD:10053604 RGD:10053606 |
NCBI chr 9:36,620,656...36,759,555
Ensembl chr 9:36,620,658...36,759,552
|
|
G |
S |
Atm |
ATM serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:21224054 PMID:24565947 |
RGD:10053604 RGD:10053606 |
NCBI chrNW_004936551:359,134...534,672
Ensembl chrNW_004936551:359,362...532,211
|
|
G |
D |
ATM |
ATM serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:21224054 PMID:24565947 |
RGD:10053604 RGD:10053606 |
NCBI chr 5:24,180,129...24,297,207
Ensembl chr 5:24,182,135...24,297,207
|
|
G |
B |
ATM |
ATM serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:21224054 PMID:24565947 |
RGD:10053604 RGD:10053606 |
NCBI chr11:103,109,979...103,256,405
Ensembl chr11:106,584,228...106,727,041
|
|
G |
C |
Atm |
ATM serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:21224054 PMID:24565947 |
RGD:10053604 RGD:10053606 |
NCBI chrNW_004955412:10,422,753...10,531,406
Ensembl chrNW_004955412:10,426,135...10,530,545
|
|
G |
R |
Atm |
ATM serine/threonine kinase |
treatment |
IEP ISO |
|
RGD |
PMID:24565947 PMID:21224054 |
RGD:10053604, RGD:10053606 |
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
M |
Atm |
ataxia telangiectasia mutated |
treatment |
ISO IEP |
|
RGD |
PMID:24565947 PMID:21224054 |
RGD:10053604, RGD:10053606 |
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
H |
ATM |
ATM serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:24565947 PMID:21224054 |
RGD:10053604, RGD:10053606 |
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
|
|
G |
N |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chrNW_004624748:2,112,574...2,183,994
Ensembl chrNW_004624748:2,113,094...2,205,856
|
|
G |
G |
ATP7B |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chr 3:29,817,712...29,899,302
Ensembl chr 3:29,816,860...29,899,077
|
|
G |
P |
ATP7B |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chr11:15,892,549...15,942,070
Ensembl chr11:15,876,612...15,942,064
|
|
G |
S |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chrNW_004936565:4,694,294...4,763,661
Ensembl chrNW_004936565:4,694,281...4,763,773
|
|
G |
D |
ATP7B |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chr22:162,474...225,599
Ensembl chr22:191,888...225,266
|
|
G |
B |
ATP7B |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chr13:33,063,698...33,144,528
Ensembl chr13:51,810,555...51,851,839
|
|
G |
C |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chrNW_004955431:5,228,395...5,297,120
Ensembl chrNW_004955431:5,229,126...5,269,616
|
|
G |
R |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
M |
Atp7b |
ATPase, copper transporting, beta polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321
|
|
G |
H |
ATP7B |
ATPase copper transporting beta |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25134866 |
|
NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125
|
|
G |
N |
Brip1 |
BRCA1 interacting DNA helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chrNW_004624871:2,051,044...2,195,364
Ensembl chrNW_004624871:2,052,863...2,198,165
|
|
G |
G |
BRIP1 |
BRCA1 interacting DNA helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr16:32,909,226...33,085,551
Ensembl chr16:32,910,693...33,082,587
|
|
G |
P |
BRIP1 |
BRCA1 interacting helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr12:36,498,138...36,639,847
Ensembl chr12:36,498,205...36,635,973
|
|
G |
S |
Brip1 |
BRCA1 interacting DNA helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chrNW_004936490:3,001,445...3,139,538
Ensembl chrNW_004936490:3,003,484...3,137,479
|
|
G |
D |
BRIP1 |
BRCA1 interacting helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr 9:34,804,285...34,984,640
Ensembl chr 9:34,806,535...34,983,788
|
|
G |
B |
BRIP1 |
BRCA1 interacting DNA helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr17:55,786,568...55,973,366
Ensembl chr17:60,901,073...61,083,462
|
|
G |
C |
Brip1 |
BRCA1 interacting DNA helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chrNW_004955451:2,705,834...2,820,610
Ensembl chrNW_004955451:2,707,793...2,818,592
|
|
G |
R |
Brip1 |
BRCA1 interacting helicase 1 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
M |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr11:85,948,957...86,092,041
Ensembl chr11:85,948,964...86,092,019
|
|
G |
H |
BRIP1 |
BRCA1 interacting DNA helicase 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chr17:61,679,139...61,863,528
Ensembl chr17:61,679,139...61,863,559
|
|
G |
D |
CASP12 |
caspase 12 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 5:27,162,840...27,176,964
Ensembl chr 5:27,161,700...27,177,683
|
|
G |
R |
Casp12 |
caspase 12 |
treatment |
IEP |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
M |
Casp12 |
caspase 12 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
|
|
G |
H |
CASP12 |
caspase 12 (gene/pseudogene) |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
|
|
G |
G |
CASP3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
|
|
G |
P |
CASP3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
|
|
G |
S |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
D |
CASP3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
|
|
G |
B |
CASP3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185
|
|
G |
C |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chrNW_004955403:24,315,712...24,326,271
|
|
G |
R |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
M |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
H |
CASP3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
N |
Casp8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chrNW_004624899:427,064...450,931
Ensembl chrNW_004624899:424,363...451,087
|
|
G |
G |
CASP8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
|
|
G |
P |
CASP8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
|
|
G |
S |
Casp8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chrNW_004936726:554,627...596,334
Ensembl chrNW_004936726:554,758...595,922
|
|
G |
D |
CASP8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chr37:10,362,071...10,402,108
Ensembl chr37:10,391,048...10,401,822
|
|
G |
B |
CASP8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chr2B:88,490,611...88,542,132
Ensembl chr2B:206,669,544...206,696,468
|
|
G |
C |
Casp8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chrNW_004955403:322,082...348,591
Ensembl chrNW_004955403:322,555...347,053
|
|
G |
R |
Casp8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
M |
Casp8 |
caspase 8 |
treatment |
IMP |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
H |
CASP8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:12810955 |
RGD:14695025 |
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
N |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chrNW_004624764:1,769,270...1,789,399
Ensembl chrNW_004624764:1,773,455...1,789,423
|
|
G |
G |
CASP9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr20:116,772,819...116,798,402
Ensembl chr20:116,772,155...116,798,930
|
|
G |
P |
CASP9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
|
|
G |
S |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
D |
CASP9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 2:82,033,759...82,076,710
Ensembl chr 2:82,031,563...82,090,484
|
|
G |
B |
CASP9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 1:14,630,659...14,662,865
Ensembl chr 1:15,624,666...15,656,266
|
|
G |
C |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chrNW_004955527:2,613,691...2,630,217
Ensembl chrNW_004955527:2,613,683...2,629,738
|
|
G |
R |
Casp9 |
caspase 9 |
treatment |
IEP |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
M |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
H |
CASP9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26238033 |
RGD:13782174 |
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
N |
Cast |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chrNW_004624743:15,265,930...15,405,904
Ensembl chrNW_004624743:15,346,837...15,403,150
|
|
G |
G |
CAST |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chr 4:90,496,867...90,607,019
Ensembl chr 4:90,497,754...90,605,481
|
|
G |
P |
CAST |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chr 2:103,255,738...103,378,623
Ensembl chr 2:103,255,750...103,378,623
|
|
G |
S |
Cast |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chrNW_004936523:6,688,153...6,798,184
Ensembl chrNW_004936523:6,686,519...6,798,321
|
|
G |
D |
CAST |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chr 3:12,920,514...13,031,974
Ensembl chr 3:12,922,453...13,031,959
|
|
G |
B |
CAST |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chr 5:91,972,572...92,084,657
Ensembl chr 5:97,527,071...97,636,650
|
|
G |
C |
Cast |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chrNW_004955418:15,859,951...15,974,141
Ensembl chrNW_004955418:15,862,729...15,916,169
|
|
G |
R |
Cast |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
M |
Cast |
calpastatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
|
|
G |
H |
CAST |
calpastatin |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16871587 |
|
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,247,756...96,779,595 Ensembl chr 5:96,247,756...96,779,595
|
|
G |
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein, mRNA:increased expression:serum, liver mRNA:increased expression:liver (human) |
RGD |
PMID:8283136 PMID:12579535 |
RGD:14995451 RGD:8549567 |
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
|
|
G |
P |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
ISO |
mRNA:increased expression:liver (human) protein, mRNA:increased expression:serum, liver |
RGD |
PMID:8283136 PMID:12579535 |
RGD:14995451 RGD:8549567 |
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
G |
D |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:liver (human) protein, mRNA:increased expression:serum, liver |
RGD |
PMID:8283136 PMID:12579535 |
RGD:14995451 RGD:8549567 |
NCBI chr 9:39,008,187...39,009,932
|
|
G |
B |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein, mRNA:increased expression:serum, liver mRNA:increased expression:liver (human) |
RGD |
PMID:8283136 PMID:12579535 |
RGD:14995451 RGD:8549567 |
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
|
|
G |
R |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:liver (human) protein, mRNA:increased expression:serum, liver |
RGD |
PMID:8283136 PMID:12579535 |
RGD:8549567, RGD:14995451 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
M |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:liver (human) protein, mRNA:increased expression:serum, liver |
RGD |
PMID:8283136 PMID:12579535 |
RGD:8549567, RGD:14995451 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
H |
CCL2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:liver (human) protein, mRNA:increased expression:serum, liver |
RGD |
PMID:8283136 PMID:12579535 |
RGD:8549567, RGD:14995451 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
N |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chrNW_004624843:2,017,738...2,021,153
|
|
G |
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chr10:113,815,099...113,836,562
Ensembl chr10:113,832,573...113,835,736
|
|
G |
P |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chr15:129,172,743...129,176,069
|
|
G |
S |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chrNW_004936525:8,238,128...8,240,974
Ensembl chrNW_004936525:8,237,831...8,240,974
|
|
G |
D |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chr25:40,506,385...40,509,903
Ensembl chr25:40,506,753...40,509,709
|
|
G |
B |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chr2B:115,052,768...115,056,479
Ensembl chr2B:233,862,505...233,866,225
|
|
G |
C |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chrNW_004955453:6,846,625...6,850,007
Ensembl chrNW_004955453:6,846,549...6,850,031
|
|
G |
R |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
M |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
|
|
G |
H |
CCL20 |
C-C motif chemokine ligand 20 |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:19247846 |
RGD:14995923 |
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
R |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
M |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
|
|
G |
H |
CCL3 |
C-C motif chemokine ligand 3 |
|
IEP |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
P |
CCL3L1 |
chemokine (C-C motif) ligand 3-like 1 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr12:39,491,999...39,493,345
Ensembl chr12:39,491,914...39,493,774
|
|
G |
P |
CCL4 |
C-C motif chemokine ligand 4 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr12:39,479,190...39,480,511
Ensembl chr12:39,478,882...39,481,082
|
|
G |
D |
CCL4 |
chemokine (C-C motif) ligand 4 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr 9:37,681,342...37,682,691
Ensembl chr 9:37,676,966...37,710,209
|
|
G |
R |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
M |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
|
|
G |
H |
CCL4 |
C-C motif chemokine ligand 4 |
|
IEP |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
N |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chrNW_004624875:3,334,136...3,342,085
Ensembl chrNW_004624875:3,334,078...3,341,614
|
|
G |
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr16:29,351,214...29,361,317
|
|
G |
P |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
|
|
G |
S |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
|
|
G |
D |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
|
|
G |
B |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
|
|
G |
C |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
R |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
M |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
H |
CCL5 |
C-C motif chemokine ligand 5 |
|
IEP |
protein, mRNA:increased expression:liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
N |
Cd14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chrNW_004624743:33,372,023...33,374,438
Ensembl chrNW_004624743:33,367,898...33,373,922
|
|
G |
G |
CD14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chr23:43,264,917...43,266,825
Ensembl chr23:43,264,336...43,266,993
|
|
G |
P |
CD14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chr 2:142,348,036...142,349,686
Ensembl chr 2:142,346,360...142,349,581
|
|
G |
S |
Cd14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chrNW_004936531:9,572,392...9,575,771
Ensembl chrNW_004936531:9,571,796...9,575,923
|
|
G |
D |
CD14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chr 2:35,790,505...35,792,967
|
|
G |
B |
CD14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chr 5:135,996,265...135,997,909
Ensembl chr 5:142,113,082...142,118,966
|
|
G |
C |
Cd14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
|
|
G |
R |
Cd14 |
CD14 molecule |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
M |
Cd14 |
CD14 antigen |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
H |
CD14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:18070011 |
RGD:4144156 |
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
N |
Cd74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chrNW_004624774:9,699,876...9,708,871
Ensembl chrNW_004624774:9,700,393...9,709,514
|
|
G |
G |
CD74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chr23:53,008,802...53,022,953
Ensembl chr23:53,009,394...53,022,923
|
|
G |
P |
CD74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chr 2:151,402,210...151,409,924
Ensembl chr 2:151,402,211...151,409,833
|
|
G |
S |
Cd74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chrNW_004936504:4,522,576...4,532,289
Ensembl chrNW_004936504:4,522,751...4,531,750
|
|
G |
D |
CD74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chr 4:58,689,745...58,698,421
Ensembl chr 4:58,689,752...58,698,151
|
|
G |
B |
CD74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chr 5:145,825,635...145,836,916
Ensembl chr 5:151,830,311...151,841,334
|
|
G |
C |
Cd74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chrNW_004955415:4,129,151...4,138,336
Ensembl chrNW_004955415:4,129,254...4,137,826
|
|
G |
R |
Cd74 |
CD74 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
M |
Cd74 |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chr18:60,936,921...60,945,724
Ensembl chr18:60,936,920...60,945,724
|
|
G |
H |
CD74 |
CD74 molecule |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16799971 |
|
NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
|
|
G |
N |
Col1a2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chrNW_004624813:1,174,071...1,209,929
Ensembl chrNW_004624813:1,174,224...1,209,616
|
|
G |
G |
COL1A2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chr21:54,602,780...54,639,832
Ensembl chr21:54,602,398...54,632,780
|
|
G |
P |
COL1A2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chr 9:74,174,484...74,210,407
Ensembl chr 9:74,173,931...74,210,397
|
|
G |
S |
Col1a2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chrNW_004936585:5,650,322...5,686,393
Ensembl chrNW_004936585:5,651,180...5,685,923
|
|
G |
D |
COL1A2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chr14:19,883,731...19,919,527
Ensembl chr14:19,883,868...19,919,527
|
|
G |
B |
COL1A2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chr 7:86,344,657...86,381,282
Ensembl chr 7:99,935,185...99,971,803
|
|
G |
C |
Col1a2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chrNW_004955432:11,127,961...11,164,145
Ensembl chrNW_004955432:11,128,112...11,163,302
|
|
G |
R |
Col1a2 |
collagen type I alpha 2 chain |
|
IEP |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
M |
Col1a2 |
collagen, type I, alpha 2 |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
|
|
G |
H |
COL1A2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:11786959 |
RGD:7257539 |
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
N |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18756972 PMID:21550386 |
RGD:11039421 RGD:11039537 |
NCBI chrNW_004624795:3,162,999...3,167,248
Ensembl chrNW_004624795:3,163,009...3,166,594
|
|
G |
G |
CSF3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18756972 PMID:21550386 |
RGD:11039421 RGD:11039537 |
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
|
|
G |
P |
CSF3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18756972 PMID:21550386 |
RGD:11039421 RGD:11039537 |
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
|
|
G |
S |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18756972 PMID:21550386 |
RGD:11039421 RGD:11039537 |
NCBI chrNW_004936490:15,142,526...15,146,375
Ensembl chrNW_004936490:15,142,808...15,144,487
|
|
G |
D |
CSF3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18756972 PMID:21550386 |
RGD:11039421 RGD:11039537 |
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
|
|
G |
B |
CSF3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18756972 PMID:21550386 |
RGD:11039421 RGD:11039537 |
NCBI chr17:17,271,074...17,273,493
Ensembl chr17:17,491,276...17,493,729
|
|
G |
C |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18756972 PMID:21550386 |
RGD:11039421 RGD:11039537 |
NCBI chrNW_004955451:14,688,181...14,690,126
Ensembl chrNW_004955451:14,688,181...14,690,126
|
|
G |
R |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21550386 PMID:18756972 PMID:21550386 |
RGD:11039421, RGD:11039537 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
M |
Csf3 |
colony stimulating factor 3 (granulocyte) |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21550386 PMID:18756972 PMID:21550386 |
RGD:11039421, RGD:11039537 |
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
H |
CSF3 |
colony stimulating factor 3 |
treatment |
IDA EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21550386 PMID:18756972 PMID:21550386 |
RGD:11039421, RGD:11039537 |
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
|
|
G |
N |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chrNW_004624757:14,989,241...14,991,650
Ensembl chrNW_004624757:14,989,084...14,991,910
|
|
G |
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
|
|
G |
P |
CXCL10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
|
|
G |
S |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chrNW_004936676:60,869...63,028
Ensembl chrNW_004936676:60,621...63,106
|
|
G |
D |
CXCL10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
|
|
G |
B |
CXCL10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
|
|
G |
C |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
|
|
G |
R |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
M |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
IEP |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
H |
CXCL10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
|
RGD |
PMID:23227188 |
RGD:27095895 |
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
N |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chrNW_004624826:7,438,632...7,507,322
Ensembl chrNW_004624826:7,438,682...7,507,012
|
|
G |
G |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chr25:59,465,610...59,539,022
Ensembl chr25:59,466,378...59,538,872
|
|
G |
P |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chr 4:81,403,273...81,484,908
Ensembl chr 4:81,403,274...81,485,066
|
|
G |
S |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chrNW_004936481:17,114,441...17,178,902
Ensembl chrNW_004936481:17,114,480...17,178,844
|
|
G |
D |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chr 7:28,999,481...29,069,603
Ensembl chr 7:28,999,512...29,069,296
|
|
G |
B |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chr 1:144,996,757...145,070,046
Ensembl chr 1:148,718,897...148,790,915
|
|
G |
C |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chrNW_004955462:7,695,004...7,757,832
Ensembl chrNW_004955462:7,694,939...7,757,463
|
|
G |
R |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
M |
F5 |
coagulation factor V |
severity |
ISO |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
|
|
G |
H |
F5 |
coagulation factor V |
severity |
IEP |
protein:altered expression (human) |
RGD |
PMID:1740285 |
RGD:14700653 |
NCBI chr 1:169,511,951...169,586,481
Ensembl chr 1:169,511,951...169,586,588
|
|
G |
N |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624793:780,057...788,105
Ensembl chrNW_004624793:780,059...788,095
|
|
G |
G |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 3:91,109,864...91,122,707
Ensembl chr 3:91,110,380...91,123,327
|
|
G |
P |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr11:78,512,389...78,518,668
Ensembl chr11:78,512,137...78,518,668
|
|
G |
S |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936472:505,751...515,375
Ensembl chrNW_004936472:505,751...514,339
|
|
G |
D |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr22:60,572,459...60,582,743
Ensembl chr22:60,571,822...60,597,024
|
|
G |
B |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr13:94,246,694...94,261,133
Ensembl chr13:113,315,868...113,329,995
|
|
G |
C |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955404:685,170...692,797
Ensembl chrNW_004955404:680,594...693,665
|
|
G |
R |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
M |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
|
|
G |
H |
F7 |
coagulation factor VII |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
|
|
G |
G |
FABP1 |
fatty acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr14:18,660,058...18,666,730
Ensembl chr14:18,659,836...18,667,127
|
|
G |
P |
FABP1 |
fatty acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 3:57,850,511...57,854,966
Ensembl chr 3:57,850,499...57,854,956
|
|
G |
S |
Fabp1 |
fatty acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936712:738,361...743,073
Ensembl chrNW_004936712:738,348...743,955
|
|
G |
D |
FABP1 |
fatty acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr17:38,242,119...38,247,969
Ensembl chr17:38,242,119...38,247,962
|
|
G |
B |
FABP1 |
fatty acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr2A:87,256,032...87,303,505
Ensembl chr2A:89,165,315...89,170,448
|
|
G |
R |
Fabp1 |
fatty acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
M |
Fabp1 |
fatty acid binding protein 1, liver |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 6:71,176,863...71,182,018
Ensembl chr 6:71,176,811...71,182,007
|
|
G |
H |
FABP1 |
fatty acid binding protein 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
|
|
G |
N |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
protein:increased expression:hepatocyte: mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10950056 PMID:12828076 PMID:25601293 PMID:28060213 |
RGD:14700667 RGD:14700678 RGD:14700697 |
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
|
|
G |
P |
FAS |
Fas cell surface death receptor |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver: protein:increased expression:hepatocyte: |
CTD RGD |
PMID:10950056 PMID:12828076 PMID:25601293 PMID:28060213 |
RGD:14700667 RGD:14700678 RGD:14700697 |
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
|
|
G |
S |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
mRNA,protein:increased expression:liver: protein:increased expression:hepatocyte: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10950056 PMID:12828076 PMID:25601293 PMID:28060213 |
RGD:14700667 RGD:14700678 RGD:14700697 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
D |
FAS |
Fas cell surface death receptor |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:hepatocyte: mRNA,protein:increased expression:liver: |
RGD CTD |
PMID:10950056 PMID:12828076 PMID:25601293 PMID:28060213 |
RGD:14700667 RGD:14700678 RGD:14700697 |
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
|
|
G |
B |
FAS |
Fas cell surface death receptor |
treatment |
ISO |
protein:increased expression:hepatocyte: CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver: |
RGD CTD |
PMID:10950056 PMID:12828076 PMID:25601293 PMID:28060213 |
RGD:14700667 RGD:14700678 RGD:14700697 |
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
|
|
G |
C |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
protein:increased expression:hepatocyte: mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10950056 PMID:12828076 PMID:25601293 PMID:28060213 |
RGD:14700667 RGD:14700678 RGD:14700697 |
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
|
|
G |
R |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:hepatocyte: mRNA,protein:increased expression:liver: |
CTD RGD |
PMID:12828076 PMID:10950056 PMID:28060213 PMID:25601293 PMID:25601293 |
RGD:14700697, RGD:14700678, RGD:14700667, RGD:14700667 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
M |
Fas |
Fas cell surface death receptor |
treatment |
ISO IMP IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:hepatocyte: mRNA,protein:increased expression:liver: |
CTD RGD |
PMID:12828076 PMID:10950056 PMID:28060213 PMID:25601293 PMID:25601293 |
RGD:14700697, RGD:14700678, RGD:14700667, RGD:14700667 |
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
H |
FAS |
Fas cell surface death receptor |
treatment |
EXP IEP IMP ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:hepatocyte: mRNA,protein:increased expression:liver: |
CTD RGD |
PMID:12828076 PMID:10950056 PMID:28060213 PMID:25601293 PMID:25601293 |
RGD:14700697, RGD:14700678, RGD:14700667, RGD:14700667 |
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
M |
Fasl |
Fas ligand |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver, lymphocyte, serum: mRNA,protein:increased expression:liver: mRNA:increased expression:liver |
CTD RGD |
PMID:19505222 PMID:10950056 PMID:18946736 PMID:16279913 |
RGD:14700697, RGD:14700674, RGD:14401578 |
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
N |
Faslg |
Fas ligand |
|
ISO |
mRNA, protein:increased expression:liver, lymphocyte, serum: mRNA,protein:increased expression:liver: mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10950056 PMID:16279913 PMID:18946736 PMID:19505222 |
RGD:14401578 RGD:14700674 RGD:14700697 |
NCBI chrNW_004624771:9,031,978...9,038,760
Ensembl chrNW_004624771:9,032,016...9,038,825
|
|
G |
G |
FASLG |
Fas ligand |
|
ISO |
mRNA,protein:increased expression:liver: mRNA:increased expression:liver mRNA, protein:increased expression:liver, lymphocyte, serum: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10950056 PMID:16279913 PMID:18946736 PMID:19505222 |
RGD:14401578 RGD:14700674 RGD:14700697 |
NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
|
|
G |
P |
FASLG |
Fas ligand |
|
ISO |
mRNA, protein:increased expression:liver, lymphocyte, serum: mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver |
RGD CTD |
PMID:10950056 PMID:16279913 PMID:18946736 PMID:19505222 |
RGD:14401578 RGD:14700674 RGD:14700697 |
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
|
|
G |
S |
Faslg |
Fas ligand |
|
ISO |
mRNA:increased expression:liver mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver, lymphocyte, serum: |
RGD CTD |
PMID:10950056 PMID:16279913 PMID:18946736 PMID:19505222 |
RGD:14401578 RGD:14700674 RGD:14700697 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
D |
FASLG |
Fas ligand |
|
ISO |
mRNA,protein:increased expression:liver: mRNA, protein:increased expression:liver, lymphocyte, serum: CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver |
RGD CTD |
PMID:10950056 PMID:16279913 PMID:18946736 PMID:19505222 |
RGD:14401578 RGD:14700674 RGD:14700697 |
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
|
|
G |
B |
FASLG |
Fas ligand |
|
ISO |
mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver, lymphocyte, serum: mRNA:increased expression:liver |
RGD CTD |
PMID:10950056 PMID:16279913 PMID:18946736 PMID:19505222 |
RGD:14401578 RGD:14700674 RGD:14700697 |
NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281
|
|
G |
C |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver: mRNA:increased expression:liver mRNA, protein:increased expression:liver, lymphocyte, serum: |
CTD RGD |
PMID:10950056 PMID:16279913 PMID:18946736 PMID:19505222 |
RGD:14401578 RGD:14700674 RGD:14700697 |
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
|
|
G |
R |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver, lymphocyte, serum: mRNA,protein:increased expression:liver: mRNA:increased expression:liver |
CTD RGD |
PMID:19505222 PMID:10950056 PMID:18946736 PMID:16279913 |
RGD:14700697, RGD:14700674, RGD:14401578 |
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
H |
FASLG |
Fas ligand |
|
EXP IEP ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver, lymphocyte, serum: mRNA,protein:increased expression:liver: mRNA:increased expression:liver |
CTD RGD |
PMID:19505222 PMID:10950056 PMID:18946736 PMID:16279913 |
RGD:14700697, RGD:14700674, RGD:14401578 |
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
N |
Fbp1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624753:16,019,546...16,048,096
Ensembl chrNW_004624753:16,016,022...16,048,104
|
|
G |
G |
FBP1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr12:108,452,856...108,484,052
Ensembl chr12:108,453,156...108,483,775
|
|
G |
P |
FBP1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr10:27,588,609...27,622,225
Ensembl chr10:27,588,570...27,622,674
|
|
G |
S |
Fbp1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936626:3,555,835...3,581,651
Ensembl chrNW_004936626:3,555,762...3,581,659
|
|
G |
D |
FBP1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:72,099,886...72,125,266
Ensembl chr 1:72,099,881...72,125,224
|
|
G |
B |
FBP1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:65,695,082...65,731,628
Ensembl chr 9:93,825,150...93,860,968
|
|
G |
C |
Fbp1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955422:21,537,337...21,569,174
Ensembl chrNW_004955422:21,536,667...21,569,433
|
|
G |
R |
Fbp1 |
fructose-bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
M |
Fbp1 |
fructose bisphosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr13:63,012,567...63,036,112
Ensembl chr13:63,012,567...63,036,096
|
|
G |
H |
FBP1 |
fructose-bisphosphatase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:94,603,133...94,640,263
Ensembl chr 9:94,603,133...94,640,249
|
|
G |
N |
Fbp2 |
fructose-bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624753:15,981,008...16,010,389
Ensembl chrNW_004624753:15,980,116...16,010,489
|
|
G |
G |
FBP2 |
fructose-bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr12:108,486,830...108,527,443
Ensembl chr12:108,493,645...108,527,219
|
|
G |
P |
FBP2 |
fructose-bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr10:27,631,833...27,661,704
Ensembl chr10:27,631,496...27,665,246
|
|
G |
S |
Fbp2 |
fructose-bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936626:3,521,953...3,548,206
Ensembl chrNW_004936626:3,521,953...3,548,195
|
|
G |
D |
FBP2 |
fructose-bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:72,136,072...72,168,487
Ensembl chr 1:72,136,106...72,184,795
|
|
G |
B |
FBP2 |
fructose-bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:65,650,460...65,685,794
Ensembl chr 9:93,780,956...93,815,872
|
|
G |
C |
Fbp2 |
fructose-bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955422:21,508,906...21,530,296
Ensembl chrNW_004955422:21,505,857...21,530,302
|
|
G |
R |
Fbp2 |
fructose-bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
|
|
G |
M |
Fbp2 |
fructose bisphosphatase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr13:62,984,698...63,006,214
Ensembl chr13:62,984,691...63,006,236
|
|
G |
H |
FBP2 |
fructose-bisphosphatase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:94,558,720...94,593,824
Ensembl chr 9:94,558,720...94,593,824
|
|
G |
N |
Fga |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chrNW_004624858:5,848,817...5,856,448
|
|
G |
G |
FGA |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chr 7:101,127,554...101,134,881
Ensembl chr 7:101,125,791...101,134,405
|
|
G |
P |
FGA |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chr 8:74,574,870...74,584,202
Ensembl chr 8:74,574,882...74,584,202
|
|
G |
S |
Fga |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
D |
FGA |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chr15:52,238,305...52,247,017
Ensembl chr15:52,236,198...52,246,975
|
|
G |
B |
FGA |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chr 4:146,949,680...146,957,291
|
|
G |
C |
Fga |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chrNW_004955471:8,806,964...8,814,671
Ensembl chrNW_004955471:8,806,650...8,816,791
|
|
G |
R |
Fga |
fibrinogen alpha chain |
treatment |
IDA |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
M |
Fga |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
|
|
G |
H |
FGA |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24799907 |
RGD:11040538 |
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
|
|
G |
N |
Fst |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chrNW_004624759:5,799,127...5,804,802
Ensembl chrNW_004624759:5,798,067...5,805,254
|
|
G |
G |
FST |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr 4:49,773,646...49,780,343
Ensembl chr 4:49,773,980...49,780,333
|
|
G |
P |
FST |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr16:32,806,341...32,811,382
Ensembl chr16:32,805,932...32,811,421
|
|
G |
S |
Fst |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chrNW_004936480:13,990,967...13,997,248
Ensembl chrNW_004936480:13,990,929...13,997,248
|
|
G |
D |
FST |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr 4:61,779,252...61,785,666
Ensembl chr 4:61,779,259...61,783,260
|
|
G |
B |
FST |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr 5:60,544,495...60,550,516
|
|
G |
C |
Fst |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chrNW_004955446:13,925,833...13,932,104
Ensembl chrNW_004955446:13,925,776...13,932,104
|
|
G |
R |
Fst |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
M |
Fst |
follistatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr13:114,588,798...114,595,522
Ensembl chr13:114,588,826...114,595,487
|
|
G |
H |
FST |
follistatin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr 5:53,480,629...53,487,134
Ensembl chr 5:53,480,626...53,487,134
|
|
G |
N |
Gc |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chrNW_004624890:3,274,239...3,318,281
Ensembl chrNW_004624890:3,226,900...3,318,316
|
|
G |
G |
GC |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
|
|
G |
P |
GC |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
|
|
G |
S |
Gc |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chrNW_004936598:3,220,029...3,256,091
Ensembl chrNW_004936598:3,219,991...3,261,629
|
|
G |
D |
GC |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chr13:60,795,305...60,828,038
Ensembl chr13:60,795,305...60,827,929
|
|
G |
B |
GC |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chr 4:52,431,196...52,473,762
Ensembl chr 4:58,729,236...58,792,073
|
|
G |
C |
Gc |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chrNW_004955447:1,361,698...1,400,633
Ensembl chrNW_004955447:1,361,566...1,402,491
|
|
G |
R |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
M |
Gc |
vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
|
|
G |
H |
GC |
GC vitamin D binding protein |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8666322 PMID:17852808 |
|
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
|
|
G |
N |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chrNW_004624913:273,126...276,353
Ensembl chrNW_004624913:273,705...275,693
|
|
G |
G |
GFER |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chr 5:1,880,025...1,886,829
Ensembl chr 5:1,879,968...1,883,696
|
|
G |
P |
GFER |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chr 3:39,981,938...39,984,451
Ensembl chr 3:39,981,940...39,984,991
|
|
G |
S |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chrNW_004936694:2,051,362...2,053,812
Ensembl chrNW_004936694:2,051,325...2,053,818
|
|
G |
D |
GFER |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chr 6:38,948,927...38,951,300
Ensembl chr 6:38,949,484...38,951,703
|
|
G |
B |
GFER |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chr16:716,640...720,196
Ensembl chr16:2,073,064...2,076,592
|
|
G |
C |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chrNW_004955442:15,280,753...15,283,405
Ensembl chrNW_004955442:15,281,419...15,283,266
|
|
G |
R |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
|
|
G |
M |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,503
|
|
G |
H |
GFER |
growth factor, augmenter of liver regeneration |
treatment |
IDA EXP |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:15968720 PMID:23337881 |
RGD:9685775 |
NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749
|
|
G |
N |
Gpnmb |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chrNW_004624739:7,358,824...7,386,852
Ensembl chrNW_004624739:7,359,741...7,387,279
|
|
G |
G |
GPNMB |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chr21:35,037,197...35,066,143
Ensembl chr21:35,037,001...35,066,171
|
|
G |
P |
GPNMB |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chr 9:92,037,428...92,071,501
Ensembl chr 9:92,037,509...92,071,499
|
|
G |
S |
Gpnmb |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chrNW_004936478:397,200...425,663
Ensembl chrNW_004936478:397,145...424,801
|
|
G |
D |
GPNMB |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chr14:36,919,184...36,947,023
Ensembl chr14:36,919,296...36,946,643
|
|
G |
B |
GPNMB |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chr 7:23,931,220...23,959,687
Ensembl chr 7:23,539,928...23,568,624
|
|
G |
C |
Gpnmb |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chrNW_004955410:25,554,279...25,583,368
Ensembl chrNW_004955410:25,553,973...25,582,500
|
|
G |
R |
Gpnmb |
glycoprotein nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
|
|
G |
M |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
|
|
G |
H |
GPNMB |
glycoprotein nmb |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763343 |
|
NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108
|
|
G |
N |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chrNW_004624735:12,355,476...12,359,910
Ensembl chrNW_004624735:12,355,476...12,360,028
|
|
G |
G |
GPT |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chr 8:138,716,802...138,721,421
Ensembl chr 8:138,718,767...138,721,251
|
|
G |
S |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chrNW_004936470:7,765,810...7,770,837
Ensembl chrNW_004936470:7,765,703...7,768,465
|
|
G |
D |
GPT |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chr13:37,923,757...37,927,843
Ensembl chr13:37,924,422...37,926,156
|
|
G |
B |
GPT |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
Ensembl chr 8:144,259,991...144,263,737
|
|
G |
C |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chrNW_004955454:3,127,997...3,132,459
Ensembl chrNW_004955454:3,127,997...3,132,459
|
|
G |
R |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
M |
Gpt |
glutamic pyruvic transaminase, soluble |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
H |
GPT |
glutamic--pyruvic transaminase |
|
IEP |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
N |
Gsn |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chrNW_004624760:13,943,680...14,004,660
Ensembl chrNW_004624760:13,943,888...13,969,905
|
|
G |
G |
GSN |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chr12:18,253,079...18,317,285
Ensembl chr12:18,253,324...18,285,938
|
|
G |
P |
GSN |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chr 1:261,295,711...261,372,848
Ensembl chr 1:261,307,008...261,372,848
|
|
G |
S |
Gsn |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chrNW_004936487:9,749,755...9,802,787
Ensembl chrNW_004936487:9,764,944...9,802,841
|
|
G |
D |
GSN |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chr11:74,248,227...74,268,129
Ensembl chr11:74,233,457...74,268,129
|
|
G |
B |
GSN |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chr 9:92,413,819...92,460,483
Ensembl chr 9:120,741,148...120,805,831
|
|
G |
C |
Gsn |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chrNW_004955419:6,682,202...6,733,361
Ensembl chrNW_004955419:6,682,058...6,733,361
|
|
G |
R |
Gsn |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
M |
Gsn |
gelsolin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
|
|
G |
H |
GSN |
gelsolin |
|
IEP |
protein:decreased expression:blood serum (human) |
RGD |
PMID:9142022 |
RGD:329333022 |
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
|
|
G |
M |
H4c1 |
H4 clustered histone 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr13:23,944,778...23,945,232
Ensembl chr13:23,944,675...23,945,213
|
|
G |
H |
H4C1 |
H4 clustered histone 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 6:26,021,649...26,022,050
Ensembl chr 6:26,021,649...26,022,847
|
|
G |
N |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chrNW_004624739:30,233,589...30,307,508
Ensembl chrNW_004624739:30,236,146...30,307,356
|
|
G |
G |
HGF |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chr21:67,118,785...67,193,506
Ensembl chr21:67,120,722...67,193,504
|
|
G |
P |
HGF |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
|
|
G |
S |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chrNW_004936734:354,798...428,356
Ensembl chrNW_004936734:356,115...428,779
|
|
G |
D |
HGF |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
|
|
G |
B |
HGF |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chr 7:73,667,618...73,738,960
Ensembl chr 7:87,327,798...87,397,811
|
|
G |
C |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chrNW_004955410:4,114,280...4,181,953
Ensembl chrNW_004955410:4,114,778...4,182,058
|
|
G |
R |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
M |
Hgf |
hepatocyte growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
|
|
G |
H |
HGF |
hepatocyte growth factor |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12479984 |
|
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
|
|
G |
R |
Hist1h4m |
histone cluster 1, H4m |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr17:42,698,016...42,698,420
Ensembl chr17:42,698,025...42,698,958
|
|
G |
N |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chrNW_004624880:2,070,410...2,075,069
Ensembl chrNW_004624880:2,070,523...2,079,421
|
|
G |
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chr 1:114,447,348...114,452,693
Ensembl chr 1:114,446,544...114,451,562
|
|
G |
P |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chr 9:49,982,278...49,986,760
Ensembl chr 9:49,982,284...49,990,508
|
|
G |
S |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chrNW_004936542:7,577,192...7,581,598
Ensembl chrNW_004936542:7,577,149...7,581,923
|
|
G |
D |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chr 5:11,292,219...11,296,851
Ensembl chr 5:11,292,262...11,296,797
|
|
G |
B |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chr11:117,890,545...117,895,262
Ensembl chr11:121,809,800...121,815,773
|
|
G |
C |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chrNW_004955412:23,863,513...23,867,984
Ensembl chrNW_004955412:23,862,590...23,867,984
|
|
G |
R |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
M |
Hspa8 |
heat shock protein 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
|
|
G |
H |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:15270078 |
RGD:4891447 |
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
N |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624765:7,806,560...7,825,520
|
|
G |
G |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr10:94,021,002...94,039,997
Ensembl chr10:94,020,818...94,039,975
|
|
G |
P |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr15:111,341,153...111,362,330
Ensembl chr15:111,341,153...111,362,296
|
|
G |
S |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
|
|
G |
D |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr37:16,512,027...16,531,269
Ensembl chr37:16,512,770...16,531,219
|
|
G |
B |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr2B:95,475,320...95,494,286
Ensembl chr2B:213,599,036...213,617,175
|
|
G |
C |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367
|
|
G |
R |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
M |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
|
|
G |
H |
IDH1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
|
|
G |
N |
Il10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chrNW_004624807:4,687,249...4,691,658
Ensembl chrNW_004624807:4,687,176...4,691,732
|
|
G |
G |
IL10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
|
|
G |
P |
IL10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
S |
Il10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
D |
IL10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
|
|
G |
B |
IL10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
|
|
G |
C |
Il10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
R |
Il10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
M |
Il10 |
interleukin 10 |
|
ISO |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
H |
IL10 |
interleukin 10 |
|
IAGP |
DNA:SNPs:promoter:-1082A>G (rs1800896), -819T>C (rs1800871), -592A>C (rs1800872) (human) |
RGD |
PMID:30109600 |
RGD:14975142 |
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
N |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human gene-expressing stem cells CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chrNW_004624749:13,210,365...13,224,471
Ensembl chrNW_004624749:13,210,476...13,225,890
|
|
G |
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: therapeutic rat model treated with human gene-expressing stem cells |
CTD RGD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G |
P |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: therapeutic rat model treated with human gene-expressing stem cells |
CTD RGD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
|
|
G |
S |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: therapeutic rat model treated with human gene-expressing stem cells |
CTD RGD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G |
D |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human gene-expressing stem cells CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
|
|
G |
B |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human gene-expressing stem cells CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
|
|
G |
C |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human gene-expressing stem cells CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
|
|
G |
R |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human gene-expressing stem cells CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
M |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
rat model treated with human gene-expressing stem cells CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
H |
IL1RN |
interleukin 1 receptor antagonist |
|
IMP EXP |
rat model treated with human gene-expressing stem cells CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:20644519 PMID:22844472 |
RGD:6909176 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
N |
Il6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chrNW_004624739:7,957,709...7,963,414
Ensembl chrNW_004624739:7,957,674...7,962,318
|
|
G |
G |
IL6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
|
|
G |
P |
IL6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
S |
Il6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
D |
IL6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
|
|
G |
B |
IL6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chr 7:23,415,922...23,420,767
|
|
G |
C |
Il6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
R |
Il6 |
interleukin 6 |
treatment |
IDA |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
M |
Il6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
H |
IL6 |
interleukin 6 |
treatment |
ISO |
|
RGD |
PMID:27085796 |
RGD:11062151 |
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
N |
Inhba |
inhibin subunit beta A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chrNW_004624740:19,458,835...19,482,570
Ensembl chrNW_004624740:19,464,289...19,482,888
|
|
G |
G |
INHBA |
inhibin subunit beta A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr21:16,936,054...16,951,430
Ensembl chr21:16,936,175...16,946,880
|
|
G |
P |
INHBA |
inhibin subunit beta A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr12:53,115,379...53,117,128 NCBI chr18:52,889,684...52,909,260
Ensembl chr18:52,889,684...52,900,967
|
|
G |
S |
Inhba |
inhibin subunit beta A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chrNW_004936478:16,878,725...16,884,065
|
|
G |
D |
INHBA |
inhibin subunit beta A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr18:8,272,978...8,288,432
Ensembl chr18:8,272,872...8,283,794
|
|
G |
B |
INHBA |
inhibin subunit beta A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr 7:42,538,591...42,556,578
Ensembl chr 7:42,580,730...42,595,097
|
|
G |
C |
Inhba |
inhibin subunit beta A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chrNW_004955460:2,054,879...2,066,628
Ensembl chrNW_004955460:2,046,588...2,066,609
|
|
G |
R |
Inhba |
inhibin subunit beta A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
M |
Inhba |
inhibin beta-A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206
|
|
G |
H |
INHBA |
inhibin subunit beta A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12560755 |
|
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
|
|
G |
N |
Ins |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chrNW_004624767:14,999,088...15,000,035
Ensembl chrNW_004624767:14,999,088...15,000,035
|
|
G |
G |
INS |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chr 1:1,965,128...1,969,090
|
|
G |
P |
INS |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chr 2:1,496,842...1,498,052
Ensembl chr 2:1,496,842...1,497,841
|
|
G |
S |
Ins |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chrNW_004936816:1,002,137...1,003,357
Ensembl chrNW_004936816:1,002,137...1,003,357
|
|
G |
D |
INS |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
|
|
G |
B |
INS |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chr11:2,200,785...2,202,579
Ensembl chr11:2,218,117...2,231,666
|
|
G |
C |
Ins |
insulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
|
|
G |
H |
INS |
insulin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
|
|
G |
H |
INS-IGF2 |
INS-IGF2 readthrough |
|
ISO |
mRNA:increased expression:pancreatic islet |
RGD |
PMID:17097861 |
RGD:2298712 |
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
R |
Ins1 |
insulin 1 |
|
IEP |
mRNA:increased expression:pancreatic islet |
RGD |
PMID:17097861 |
RGD:2298712 |
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
M |
Ins1 |
insulin I |
|
ISO |
mRNA:increased expression:pancreatic islet |
RGD |
PMID:17097861 |
RGD:2298712 |
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
R |
Ins2 |
insulin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
M |
Ins2 |
insulin II |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12639207 |
|
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
|
|
G |
N |
Kcnj10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chrNW_004624794:1,180,822...1,211,781
Ensembl chrNW_004624794:1,180,834...1,212,456
|
|
G |
G |
KCNJ10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chr20:3,873,915...3,907,587
Ensembl chr20:3,902,513...3,903,652
|
|
G |
P |
KCNJ10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chr 4:90,421,956...90,457,406
Ensembl chr 4:90,422,025...90,457,406
|
|
G |
S |
Kcnj10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chrNW_004936740:555,948...589,219
Ensembl chrNW_004936740:555,998...586,353
|
|
G |
D |
KCNJ10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chr38:22,114,718...22,143,625
Ensembl chr38:22,130,508...22,140,813
|
|
G |
B |
KCNJ10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chr 1:135,391,321...135,424,100
|
|
G |
C |
Kcnj10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chrNW_004955468:11,828,525...11,860,365
Ensembl chrNW_004955468:11,828,525...11,860,365
|
|
G |
R |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
|
IEP |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
|
|
G |
M |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chr 1:172,168,777...172,201,652
Ensembl chr 1:172,168,777...172,201,652
|
|
G |
H |
KCNJ10 |
potassium inwardly rectifying channel subfamily J member 10 |
|
ISO |
mRNA, protein:decreased expression:cerebral cortex |
RGD |
PMID:21538466 |
RGD:8662894 |
NCBI chr 1:160,037,467...160,070,160
Ensembl chr 1:159,998,651...160,070,483
|
|
G |
N |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chrNW_004624761:14,733,912...14,831,428
|
|
G |
G |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chr 7:13,808,104...13,891,003
Ensembl chr 7:13,808,037...13,890,976
|
|
G |
P |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
|
|
G |
S |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chrNW_004936482:17,162,854...17,238,319
Ensembl chrNW_004936482:17,162,950...17,238,274
|
|
G |
D |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chr13:47,108,442...47,190,935
Ensembl chr13:47,108,504...47,190,029
|
|
G |
B |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chr 4:69,199,543...69,282,323
Ensembl chr 4:75,761,946...75,844,473
|
|
G |
C |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chrNW_004955447:16,149,014...16,226,151
Ensembl chrNW_004955447:16,148,605...16,226,734
|
|
G |
R |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
M |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382
|
|
G |
H |
KIT |
KIT proto-oncogene, receptor tyrosine kinase |
|
IEP |
mRNA:increased expression:liver: |
RGD |
PMID:10385646 |
RGD:12910730 |
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
|
|
G |
N |
Krt18 |
keratin 18 |
|
ISO |
protein:increased degradation:serum (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17847110 PMID:20538000 |
RGD:18337491 |
NCBI chrNW_004624904:1,011,675...1,015,319
Ensembl chrNW_004624904:1,011,755...1,015,416
|
|
G |
G |
KRT18 |
keratin 18 |
|
ISO |
protein:increased degradation:serum (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17847110 PMID:20538000 |
RGD:18337491 |
NCBI chr11:49,073,733...49,081,706
|
|
G |
P |
KRT18 |
keratin 18 |
|
ISO |
protein:increased degradation:serum (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17847110 PMID:20538000 |
RGD:18337491 |
NCBI chr 5:18,217,686...18,221,432
Ensembl chr 5:18,217,691...18,221,429
|
|
G |
S |
Krt18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased degradation:serum (human) |
CTD RGD |
PMID:17847110 PMID:20538000 |
RGD:18337491 |
NCBI chrNW_004936512:10,290,706...10,294,647
Ensembl chrNW_004936512:10,290,690...10,294,651
|
|
G |
D |
KRT18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased degradation:serum (human) |
CTD RGD |
PMID:17847110 PMID:20538000 |
RGD:18337491 |
NCBI chr27:2,189,269...2,193,368
Ensembl chr27:2,189,269...2,193,368
|
|
G |
B |
KRT18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased degradation:serum (human) |
CTD RGD |
PMID:17847110 PMID:20538000 |
RGD:18337491 |
NCBI chr12:35,807,660...35,811,691
Ensembl chr12:36,587,149...36,591,196
|
|
G |
C |
Krt18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased degradation:serum (human) |
CTD RGD |
PMID:17847110 PMID:20538000 |
RGD:18337491 |
NCBI chrNW_004955458:227,017...230,752
Ensembl chrNW_004955458:226,805...232,728
|
|
G |
R |
Krt18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased degradation:serum (human) |
CTD RGD |
PMID:20538000 PMID:17847110 |
RGD:18337491 |
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
M |
Krt18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased degradation:serum (human) |
CTD RGD |
PMID:20538000 PMID:17847110 |
RGD:18337491 |
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
|
|
G |
H |
KRT18 |
keratin 18 |
|
EXP IEP |
CTD Direct Evidence: marker/mechanism protein:increased degradation:serum (human) |
CTD RGD |
PMID:20538000 PMID:17847110 |
RGD:18337491 |
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
|
|
G |
N |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chrNW_004624904:970,136...978,211
|
|
G |
G |
KRT8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chr11:49,027,879...49,051,753
|
|
G |
P |
KRT8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chr 5:18,172,423...18,180,277
Ensembl chr 5:18,167,553...18,180,404
|
|
G |
S |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chrNW_004936512:10,247,049...10,254,748
Ensembl chrNW_004936512:10,246,991...10,254,827
|
|
G |
D |
KRT8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chr27:2,221,608...2,229,343
|
|
G |
B |
KRT8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chr12:35,855,367...35,863,248
Ensembl chr12:36,634,582...36,642,564
|
|
G |
C |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chrNW_004955458:178,954...190,310
|
|
G |
R |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
M |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
|
|
G |
H |
KRT8 |
keratin 8 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20538000 |
|
NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954
|
|
G |
G |
LDHA |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:46,525,090...46,542,587
|
|
G |
P |
LDHA |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,814,169...40,826,715
|
|
G |
S |
Ldha |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936528:866,607...879,977
|
|
G |
D |
LDHA |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr21:40,829,844...40,840,947
|
|
G |
B |
LDHA |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr11:18,432,347...18,445,694
Ensembl chr11:18,115,250...18,128,400
|
|
G |
C |
Ldha |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955414:33,087,745...33,100,846
|
|
G |
R |
Ldha |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
M |
Ldha |
lactate dehydrogenase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
|
|
G |
H |
LDHA |
lactate dehydrogenase A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
|
|
G |
D |
LOC100856533 |
alcohol dehydrogenase E chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr32:21,422,428...21,437,058
|
|
G |
B |
LOC100971436 |
alcohol dehydrogenase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 4:91,697,663...91,712,314
Ensembl chr 4:102,359,419...102,374,101
|
|
G |
B |
LOC100988585 |
transmembrane protein 220 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chr17:40,923,397...40,973,382
Ensembl chr17:45,703,642...45,720,520 Ensembl chr17:45,703,642...45,720,520
|
|
G |
N |
LOC101701770 |
protein SCO1 homolog, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chrNW_004624786:13,038,384...13,053,250
Ensembl chrNW_004624786:13,036,426...13,053,210
|
|
G |
N |
LOC101707460 |
histone H4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624756:881,773...882,657
|
|
G |
S |
LOC101974307 |
protein SCO1 homolog, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chrNW_004936595:3,523,789...3,537,933
Ensembl chrNW_004936595:3,523,779...3,538,150
|
|
G |
S |
LOC101974797 |
histone H3.1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936671:1,881,645...1,882,070
|
|
G |
C |
LOC102030058 |
protein SCO1 homolog, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chrNW_004955467:6,519,873...6,535,321
Ensembl chrNW_004955467:6,519,873...6,537,753
|
|
G |
G |
LOC103242767 |
C-C motif chemokine 3 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr16:29,887,799...29,897,664
Ensembl chr16:29,887,883...29,897,544
|
|
G |
S |
LOC120889510 |
insulin |
|
ISO |
mRNA:increased expression:pancreatic islet |
RGD |
PMID:17097861 |
RGD:2298712 |
|
|
G |
D |
LOC480600 |
chemokine (C-C motif) ligand 3 |
|
ISO |
protein, mRNA:increased expression:serum, liver |
RGD |
PMID:12579535 |
RGD:14995451 |
NCBI chr 9:37,708,561...37,710,209
Ensembl chr 9:37,676,966...37,710,209
|
|
G |
N |
Lrp1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chrNW_004624802:10,734,907...10,812,888
Ensembl chrNW_004624802:10,734,263...10,812,763
|
|
G |
G |
LRP1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chr11:53,039,147...53,125,041
Ensembl chr11:53,039,364...53,125,776
|
|
G |
P |
LRP1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chr 5:22,435,636...22,519,276
|
|
G |
S |
Lrp1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chrNW_004936646:1,326,900...1,407,236
Ensembl chrNW_004936646:1,327,374...1,406,456
|
|
G |
D |
LRP1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chr10:1,260,256...1,341,705
Ensembl chr10:1,260,719...1,352,271
|
|
G |
B |
LRP1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chr12:31,713,938...31,799,287
Ensembl chr12:31,966,149...32,051,979
|
|
G |
C |
Lrp1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chrNW_004955458:4,861,431...4,941,939
Ensembl chrNW_004955458:4,861,431...4,941,146
|
|
G |
R |
Lrp1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
M |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
|
IMP |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chr10:127,374,026...127,457,158
Ensembl chr10:127,374,030...127,457,017
|
|
G |
H |
LRP1 |
LDL receptor related protein 1 |
|
ISO |
associated with Carbon Tetrachloride Poisoning |
RGD |
PMID:26237273 |
RGD:13800515 |
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
|
|
G |
N |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chrNW_004624733:42,668,963...42,673,385
Ensembl chrNW_004624733:42,670,632...42,672,846
|
|
G |
G |
LTC4S |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chr23:81,523,784...81,526,297
Ensembl chr23:81,523,775...81,526,179
|
|
G |
P |
LTC4S |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chr 2:78,799,446...78,802,281
Ensembl chr 2:78,799,449...78,802,285
|
|
G |
S |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chrNW_004936739:975,494...978,426
Ensembl chrNW_004936739:975,493...978,482
|
|
G |
D |
LTC4S |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chr11:1,893,927...1,897,028
Ensembl chr11:1,894,380...1,897,752
|
|
G |
B |
LTC4S |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chr 5:174,946,346...174,950,805
|
|
G |
C |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chrNW_004955408:788,856...791,505
|
|
G |
R |
Ltc4s |
leukotriene C4 synthase |
|
IEP |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
|
|
G |
M |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chr11:50,127,288...50,129,378
Ensembl chr11:50,127,288...50,129,443
|
|
G |
H |
LTC4S |
leukotriene C4 synthase |
|
ISO |
mRNA, protein:increased expression:liver (rat) |
RGD |
PMID:18461660 |
RGD:2302283 |
NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
|
|
G |
N |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chrNW_004624928:1,442,216...1,494,275
Ensembl chrNW_004624928:1,439,146...1,494,266
|
|
G |
G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chr 9:43,356,603...43,489,066
Ensembl chr 9:43,356,308...43,393,425
|
|
G |
P |
MAPK8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
|
|
G |
S |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chrNW_004936728:1,775,746...1,893,895
Ensembl chrNW_004936728:1,775,641...1,893,907
|
|
G |
D |
MAPK8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
|
|
G |
B |
MAPK8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chr10:45,806,748...45,936,362
|
|
G |
C |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chrNW_004955556:1,593,552...1,705,543
Ensembl chrNW_004955556:1,593,494...1,665,784
|
|
G |
R |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
M |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
H |
MAPK8 |
mitogen-activated protein kinase 8 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17185352 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
N |
Mdh1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624762:9,884,521...9,900,593
Ensembl chrNW_004624762:9,881,950...9,901,372
|
|
G |
G |
MDH1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr14:43,406,502...43,425,525
Ensembl chr14:43,406,499...43,425,095
|
|
G |
P |
MDH1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 3:78,247,229...78,263,085
Ensembl chr 3:78,244,999...78,268,600
|
|
G |
S |
Mdh1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936491:8,570,472...8,586,914
Ensembl chrNW_004936491:8,570,472...8,587,686
|
|
G |
D |
MDH1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr10:63,316,818...63,334,556
Ensembl chr10:63,316,831...63,361,735
|
|
G |
B |
MDH1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr2A:63,658,933...63,677,257
Ensembl chr2A:64,785,132...64,803,631
|
|
G |
C |
Mdh1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955424:20,707,765...20,723,493
Ensembl chrNW_004955424:20,706,058...20,723,493
|
|
G |
R |
Mdh1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
|
|
G |
M |
Mdh1 |
malate dehydrogenase 1, NAD (soluble) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr11:21,506,692...21,521,934
Ensembl chr11:21,506,692...21,522,367
|
|
G |
H |
MDH1 |
malate dehydrogenase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197
|
|
G |
N |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chrNW_004624827:2,589,157...2,724,065
Ensembl chrNW_004624827:2,587,966...2,723,995
|
|
G |
G |
MET |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chr21:85,370,574...85,486,405
Ensembl chr21:85,397,645...85,488,093
|
|
G |
P |
MET |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
|
|
G |
S |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chrNW_004936589:2,280,803...2,390,179
Ensembl chrNW_004936589:2,280,799...2,390,179
|
|
G |
D |
MET |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027
|
|
G |
B |
MET |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chr 7:108,646,278...108,772,238
Ensembl chr 7:121,365,438...121,468,159
|
|
G |
C |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
|
|
G |
R |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
M |
Met |
met proto-oncogene |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
|
|
G |
H |
MET |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17009398 |
RGD:2317515 |
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
|
|
G |
N |
Milr1 |
mast cell immunoglobulin like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chrNW_004624870:85,695...142,842
|
|
G |
G |
MILR1 |
mast cell immunoglobulin like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr16:56,799,089...56,827,030
Ensembl chr16:56,809,159...56,826,567
|
|
G |
P |
MILR1 |
mast cell immunoglobulin like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr12:14,612,177...14,637,946
Ensembl chr12:14,612,183...14,636,811
|
|
G |
S |
Milr1 |
mast cell immunoglobulin like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chrNW_004936541:4,959,838...4,972,543
|
|
G |
D |
MILR1 |
mast cell immunoglobulin like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr 9:12,251,085...12,266,608
Ensembl chr 9:12,251,186...12,266,605
|
|
G |
B |
MILR1 |
mast cell immunoglobulin like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr17:58,546,046...58,570,679
Ensembl chr17:63,638,549...63,663,193
|
|
G |
C |
Milr1 |
mast cell immunoglobulin like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chrNW_004955478:7,416,609...7,429,817
|
|
G |
R |
Milr1 |
mast cell immunoglobulin-like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr10:91,684,288...91,705,284
Ensembl chr10:91,687,831...91,705,282
|
|
G |
M |
Milr1 |
mast cell immunoglobulin like receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr11:106,641,472...106,659,620
Ensembl chr11:106,642,052...106,659,620
|
|
G |
H |
MILR1 |
mast cell immunoglobulin like receptor 1 |
|
IAGP |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr17:64,449,115...64,497,356
Ensembl chr17:64,449,037...64,492,770
|
|
G |
P |
MIR122 |
microRNA mir-122 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:24895202 |
RGD:14401602 |
NCBI chr 1:162,329,776...162,329,860
Ensembl chr 1:162,329,767...162,329,860
|
|
G |
D |
MIR122 |
microRNA mir-122 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:24895202 |
RGD:14401602 |
NCBI chr 1:17,593,858...17,593,915
Ensembl chr 1:17,593,837...17,593,929
|
|
G |
R |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:24895202 |
RGD:14401602 |
NCBI chr18:58,758,703...58,758,787
|
|
G |
M |
Mir122 |
microRNA 122 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:24895202 |
RGD:14401602 |
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
|
|
G |
H |
MIR122 |
microRNA 122 |
|
IEP |
miRNA:increased expression:serum |
RGD |
PMID:24895202 |
RGD:14401602 |
NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158
|
|
G |
P |
MIR221 |
microRNA mir-221 |
treatment |
ISO |
|
RGD |
PMID:21400558 |
RGD:18337268 |
NCBI chr X:40,571,068...40,571,137
Ensembl chr X:40,571,068...40,571,137
|
|
G |
D |
MIR221 |
microRNA mir-221 |
treatment |
ISO |
|
RGD |
PMID:21400558 |
RGD:18337268 |
NCBI chr X:39,523,890...39,523,951
Ensembl chr X:39,523,885...39,523,954
|
|
G |
R |
Mir221 |
microRNA 221 |
treatment |
ISO |
|
RGD |
PMID:21400558 |
RGD:18337268 |
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
|
|
G |
M |
Mir221 |
microRNA 221 |
treatment |
IDA |
|
RGD |
PMID:21400558 |
RGD:18337268 |
NCBI chr X:19,012,533...19,012,627
Ensembl chr X:19,012,533...19,012,627
|
|
G |
H |
MIR221 |
microRNA 221 |
treatment |
ISO |
|
RGD |
PMID:21400558 |
RGD:18337268 |
NCBI chr X:45,746,157...45,746,266
Ensembl chr X:45,746,157...45,746,266
|
|
G |
D |
MIR223 |
microRNA mir-223 |
disease_progression |
ISO |
RNA:increased expression:serum,liver |
RGD |
PMID:25562161 PMID:28646120 |
RGD:21408574 RGD:21408585 |
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
|
|
G |
R |
Mir223 |
microRNA 223 |
disease_progression |
ISO |
RNA:increased expression:serum,liver |
RGD |
PMID:28646120 PMID:25562161 |
RGD:21408574, RGD:21408585 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
M |
Mir223 |
microRNA 223 |
disease_progression |
ISO IEP |
RNA:increased expression:serum,liver |
RGD |
PMID:28646120 PMID:25562161 |
RGD:21408574, RGD:21408585 |
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
|
|
G |
H |
MIR223 |
microRNA 223 |
disease_progression |
IEP ISO |
RNA:increased expression:serum,liver |
RGD |
PMID:28646120 PMID:25562161 |
RGD:21408574, RGD:21408585 |
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
|
|
G |
P |
MT-ATP8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
disease_progression |
ISO |
associated with Endotoxemia |
RGD |
PMID:21167184 |
RGD:5490296 |
NCBI chr MT:8,959...9,162
Ensembl chr MT:8,959...9,162
|
|
G |
D |
MT-ATP8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
disease_progression |
ISO |
associated with Endotoxemia |
RGD |
PMID:21167184 |
RGD:5490296 |
NCBI chr MT:7,803...8,006
Ensembl chr MT:7,803...8,006
|
|
G |
R |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
disease_progression |
ISO |
associated with Endotoxemia |
RGD |
PMID:21167184 |
RGD:5490296 |
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
M |
mt-Atp8 |
ATP synthase 8, mitochondrial |
disease_progression |
IMP |
associated with Endotoxemia |
RGD |
PMID:21167184 |
RGD:5490296 |
NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969
|
|
G |
H |
MT-ATP8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
disease_progression |
ISO |
associated with Endotoxemia |
RGD |
PMID:21167184 |
RGD:5490296 |
NCBI chr MT:8,366...8,572
Ensembl chr MT:8,366...8,572
|
|
G |
N |
Nbas |
NBAS subunit of NRZ tethering complex |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chrNW_004624865:937,495...1,208,663
Ensembl chrNW_004624865:961,587...1,212,950
|
|
G |
G |
NBAS |
NBAS subunit of NRZ tethering complex |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chr14:92,045,416...92,475,079
Ensembl chr14:92,078,045...92,474,944
|
|
G |
P |
NBAS |
NBAS subunit of NRZ tethering complex |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chr 3:121,882,734...122,242,325
Ensembl chr 3:121,882,744...122,242,326
|
|
G |
S |
Nbas |
NBAS subunit of NRZ tethering complex |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chrNW_004936493:14,940,592...15,241,209
Ensembl chrNW_004936493:14,943,926...15,241,070
|
|
G |
D |
NBAS |
NBAS subunit of NRZ tethering complex |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chr17:11,091,536...11,410,284
Ensembl chr17:11,091,543...11,430,839
|
|
G |
B |
NBAS |
NBAS subunit of NRZ tethering complex |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chr2A:15,159,193...15,552,121
Ensembl chr2A:15,293,512...15,685,820
|
|
G |
C |
Nbas |
NBAS subunit of NRZ tethering complex |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chrNW_004955487:8,894,403...9,073,535
Ensembl chrNW_004955487:8,894,187...9,073,663
|
|
G |
R |
Nbas |
NBAS subunit of NRZ tethering complex |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984
|
|
G |
M |
Nbas |
neuroblastoma amplified sequence |
|
ISO |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chr12:13,319,102...13,687,381
Ensembl chr12:13,319,134...13,633,812
|
|
G |
H |
NBAS |
NBAS subunit of NRZ tethering complex |
|
IAGP |
DNA:mutations:multiple |
RGD |
PMID:26541327 |
RGD:25671408 |
NCBI chr 2:14,778,909...15,561,334
Ensembl chr 2:15,166,916...15,561,340
|
|
G |
N |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chrNW_004624786:491,944...530,427
Ensembl chrNW_004624786:489,311...528,271
|
|
G |
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
|
|
G |
P |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
S |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
|
|
G |
D |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
|
|
G |
B |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
|
|
G |
C |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
G |
R |
Nos2 |
nitric oxide synthase 2 |
|
IEP |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
M |
Nos2 |
nitric oxide synthase 2, inducible |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
H |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased activity:liver (rat) |
RGD |
PMID:22001939 |
RGD:5509102 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
N |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chrNW_004624800:5,600,215...5,619,020
Ensembl chrNW_004624800:5,600,212...5,619,004
|
|
G |
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chr21:119,174,829...119,196,840
|
|
G |
P |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
|
|
G |
S |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
D |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
|
|
G |
B |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
|
|
G |
C |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
|
|
G |
R |
Nos3 |
nitric oxide synthase 3 |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
M |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
H |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17276928 |
RGD:2292148 |
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
N |
Panx1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chrNW_004624735:38,766,973...38,823,284
Ensembl chrNW_004624735:38,766,981...38,819,092
|
|
G |
G |
PANX1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chr 1:85,356,507...85,413,146
Ensembl chr 1:85,356,610...85,409,275
|
|
G |
P |
PANX1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chr 9:26,443,425...26,491,010
Ensembl chr 9:26,443,815...26,491,002
|
|
G |
S |
Panx1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chrNW_004936674:736,911...773,406
Ensembl chrNW_004936674:736,905...773,412
|
|
G |
D |
PANX1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chr21:6,665,730...6,715,272
Ensembl chr21:6,668,269...6,715,858
|
|
G |
B |
PANX1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chr11:89,142,686...89,295,972
Ensembl chr11:92,628,760...92,685,109
|
|
G |
C |
Panx1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chrNW_004955414:405,483...448,470
Ensembl chrNW_004955414:401,188...448,470
|
|
G |
R |
Panx1 |
Pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:11,850,730...11,889,774
|
|
G |
M |
Panx1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chr 9:14,917,081...14,956,774
Ensembl chr 9:14,913,424...14,956,774
|
|
G |
H |
PANX1 |
pannexin 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chr11:94,128,841...94,181,968
Ensembl chr11:94,128,841...94,181,968
|
|
G |
N |
Polg2 |
DNA polymerase gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chrNW_004624870:136,060...204,486
Ensembl chrNW_004624870:177,239...204,552
|
|
G |
G |
POLG2 |
DNA polymerase gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr16:56,773,867...56,794,571
Ensembl chr16:56,776,330...56,794,654
|
|
G |
P |
POLG2 |
DNA polymerase gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr12:14,582,075...14,601,576
Ensembl chr12:14,582,544...14,601,570
|
|
G |
S |
Polg2 |
DNA polymerase gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chrNW_004936541:4,988,469...5,004,110
Ensembl chrNW_004936541:4,988,368...5,003,922
|
|
G |
D |
POLG2 |
DNA polymerase gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr 9:12,258,188...12,298,376
Ensembl chr 9:12,269,990...12,298,272
|
|
G |
B |
POLG2 |
DNA polymerase gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr17:58,574,442...58,593,915
Ensembl chr17:63,667,246...63,686,503
|
|
G |
C |
Polg2 |
DNA polymerase gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chrNW_004955478:7,376,240...7,396,647
Ensembl chrNW_004955478:7,376,712...7,396,647
|
|
G |
R |
Polg2 |
DNA polymerase gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr10:91,712,586...91,723,008
Ensembl chr10:91,712,586...91,723,008
|
|
G |
M |
Polg2 |
polymerase (DNA directed), gamma 2, accessory subunit |
|
ISO |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr11:106,659,030...106,670,363
Ensembl chr11:106,659,079...106,670,363
|
|
G |
H |
POLG2 |
DNA polymerase gamma 2, accessory subunit |
|
IAGP |
ClinVar Annotator: match by term: Acute hepatic failure |
ClinVar |
PMID:25741868 PMID:27592148 PMID:28492532 PMID:30157269 |
|
NCBI chr17:64,477,785...64,497,054
Ensembl chr17:64,477,785...64,497,054
|
|
G |
N |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chrNW_004624738:7,442,223...7,448,513
Ensembl chrNW_004624738:7,442,292...7,445,020
|
|
G |
G |
POMC |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chr14:82,491,296...82,499,289
Ensembl chr14:82,494,323...82,499,447
|
|
G |
P |
POMC |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
|
|
G |
S |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
|
|
G |
D |
POMC |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
|
|
G |
B |
POMC |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chr2A:25,161,668...25,165,600
Ensembl chr2A:25,258,768...25,262,706
|
|
G |
C |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
|
|
G |
R |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
M |
Pomc |
pro-opiomelanocortin-alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
|
|
G |
H |
POMC |
proopiomelanocortin |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15313186 |
|
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
|
|
G |
P |
PPP1R16A |
protein phosphatase 1 regulatory subunit 16A |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:28513770 |
RGD:14975169 |
NCBI chr 4:302,621...320,048
Ensembl chr 4:297,748...320,056
|
|
G |
N |
Psmd11 |
proteasome 26S subunit, non-ATPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624875:495,353...534,433
Ensembl chrNW_004624875:495,263...534,433
|
|
G |
G |
PSMD11 |
proteasome 26S subunit, non-ATPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr16:25,999,575...26,040,033
Ensembl chr16:25,999,569...26,042,793
|
|
G |
P |
PSMD11 |
proteasome 26S subunit, non-ATPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr12:42,498,711...42,529,853
Ensembl chr12:42,498,941...42,529,805
|
|
G |
S |
Psmd11 |
proteasome 26S subunit, non-ATPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936538:2,420,618...2,456,163
Ensembl chrNW_004936538:2,418,454...2,456,411
|
|
G |
D |
PSMD11 |
proteasome 26S subunit, non-ATPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 9:40,507,227...40,538,967
Ensembl chr 9:40,508,541...40,538,566
|
|
G |
B |
PSMD11 |
proteasome 26S subunit, non-ATPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr17:24,292,990...24,331,690
Ensembl chr17:24,585,755...24,621,013
|
|
G |
C |
Psmd11 |
proteasome 26S subunit, non-ATPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955481:7,364,543...7,402,770
Ensembl chrNW_004955481:7,364,543...7,405,504
|
|
G |
R |
Psmd11 |
proteasome 26S subunit, non-ATPase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
|
|
G |
M |
Psmd11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr11:80,319,441...80,364,074
Ensembl chr11:80,319,441...80,364,074
|
|
G |
H |
PSMD11 |
proteasome 26S subunit, non-ATPase 11 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr17:32,444,510...32,483,319
Ensembl chr17:32,444,379...32,483,319
|
|
G |
N |
Ptafr |
platelet activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chrNW_004624764:11,996,454...12,025,751
Ensembl chrNW_004624764:11,998,657...11,999,685
|
|
G |
G |
PTAFR |
platelet activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chr20:104,627,591...104,658,840
Ensembl chr20:104,657,179...104,658,207
|
|
G |
P |
PTAFR |
platelet activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chr 6:85,235,390...85,272,360
Ensembl chr 6:85,235,394...85,261,760
|
|
G |
S |
Ptafr |
platelet activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chrNW_004936474:12,333,905...12,337,140
Ensembl chrNW_004936474:12,336,071...12,337,099
|
|
G |
D |
PTAFR |
platelet activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chr 2:72,225,386...72,256,353
Ensembl chr 2:72,225,386...72,256,352
|
|
G |
B |
PTAFR |
platelet activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chr 1:27,405,880...27,436,184
Ensembl chr 1:28,447,833...28,448,861
|
|
G |
C |
Ptafr |
platelet activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chrNW_004955452:7,309,854...7,345,579
Ensembl chrNW_004955452:7,311,901...7,312,929
|
|
G |
R |
Ptafr |
platelet-activating factor receptor |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
|
|
G |
M |
Ptafr |
platelet-activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
|
|
G |
H |
PTAFR |
platelet activating factor receptor |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:11414308 |
RGD:10043144 |
NCBI chr 1:28,147,166...28,193,856
Ensembl chr 1:28,147,166...28,193,936
|
|
G |
N |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:14695009 RGD:2300286 |
NCBI chrNW_004624814:6,897,818...6,904,890
Ensembl chrNW_004624814:6,897,857...6,903,728
|
|
G |
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:14695009 RGD:2300286 |
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
|
|
G |
P |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:14695009 RGD:2300286 |
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
S |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:14695009 RGD:2300286 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
D |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:14695009 RGD:2300286 |
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
|
|
G |
B |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:14695009 RGD:2300286 |
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
|
|
G |
C |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:14695009 RGD:2300286 |
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
R |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
severity |
IMP ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:2300286, RGD:14695009 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
M |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
severity |
ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:2300286, RGD:14695009 |
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
H |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
severity |
IMP ISO |
human gene in mouse model |
RGD |
PMID:18336855 PMID:19017995 |
RGD:2300286, RGD:14695009 |
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
N |
Qdpr |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624755:14,333,308...14,353,949
Ensembl chrNW_004624755:14,333,235...14,357,159
|
|
G |
G |
QDPR |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr27:32,697,582...32,723,616
Ensembl chr27:32,697,599...32,723,016
|
|
G |
P |
QDPR |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 8:12,529,500...12,549,471
Ensembl chr 8:12,529,512...12,549,603
|
|
G |
S |
Qdpr |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936477:10,687,328...10,708,015
Ensembl chrNW_004936477:10,687,276...10,708,031
|
|
G |
D |
QDPR |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 3:62,970,850...62,987,512
Ensembl chr 3:62,970,121...63,028,395
|
|
G |
B |
QDPR |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 4:11,906,439...11,932,311
Ensembl chr 4:17,199,772...17,225,667
|
|
G |
C |
Qdpr |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955480:6,646,088...6,666,866
Ensembl chrNW_004955480:6,646,088...6,669,526
|
|
G |
R |
Qdpr |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr14:65,670,251...65,683,853
Ensembl chr14:65,670,131...65,683,854
|
|
G |
M |
Qdpr |
quinoid dihydropteridine reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 5:45,591,374...45,607,571
Ensembl chr 5:45,591,363...45,607,578
|
|
G |
H |
QDPR |
quinoid dihydropteridine reductase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 4:17,486,395...17,512,090
Ensembl chr 4:17,460,261...17,512,206
|
|
G |
N |
Rida |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004624763:5,249,905...5,263,994
Ensembl chrNW_004624763:5,247,715...5,263,880
|
|
G |
G |
RIDA |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 8:93,014,986...93,031,499
|
|
G |
P |
RIDA |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 4:38,656,270...38,665,863
Ensembl chr 4:38,656,319...38,670,987
|
|
G |
S |
Rida |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004936470:44,710,481...44,721,159
|
|
G |
D |
RIDA |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr13:348,744...361,063
Ensembl chr13:348,860...361,522
|
|
G |
B |
RIDA |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 8:94,739,120...94,753,934
Ensembl chr 8:96,923,776...96,938,512
|
|
G |
C |
Rida |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chrNW_004955417:13,810,596...13,822,982
Ensembl chrNW_004955417:13,810,596...13,822,982
|
|
G |
R |
Rida |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
|
|
G |
M |
Rida |
reactive intermediate imine deaminase A homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr15:34,484,168...34,495,392
Ensembl chr15:34,484,167...34,495,401
|
|
G |
H |
RIDA |
reactive intermediate imine deaminase A homolog |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35172013 |
|
NCBI chr 8:98,102,344...98,117,171
Ensembl chr 8:98,102,344...98,117,171
|
|
G |
N |
Rint1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chrNW_004624739:24,011,327...24,039,146
Ensembl chrNW_004624739:24,008,072...24,039,215
|
|
G |
G |
RINT1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chr21:74,454,916...74,491,057
Ensembl chr21:74,454,947...74,490,768
|
|
G |
P |
RINT1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chr 9:105,392,853...105,430,198
Ensembl chr 9:105,392,864...105,430,160
|
|
G |
S |
Rint1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chrNW_004936479:18,311,698...18,334,946
Ensembl chrNW_004936479:18,311,699...18,340,816
|
|
G |
D |
RINT1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chr18:14,843,820...14,877,334
Ensembl chr18:14,843,829...14,877,607
|
|
G |
B |
RINT1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chr 7:97,522,208...97,567,897
Ensembl chr 7:110,252,776...110,287,702
|
|
G |
C |
Rint1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chrNW_004955410:10,121,322...10,144,748
Ensembl chrNW_004955410:10,121,219...10,144,748
|
|
G |
R |
Rint1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chr 4:11,319,416...11,355,740
Ensembl chr 4:11,320,955...11,355,736
|
|
G |
M |
Rint1 |
RAD50 interactor 1 |
|
ISO |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chr 5:23,992,700...24,028,582
Ensembl chr 5:23,992,709...24,025,367
|
|
G |
H |
RINT1 |
RAD50 interactor 1 |
|
IAGP |
ClinVar Annotator: match by term: Fulminant hepatic failure |
ClinVar |
PMID:25050558 PMID:25741868 PMID:28492532 PMID:31204009 PMID:32283892 PMID:33099839 More...
|
|
NCBI chr 7:105,532,201...105,567,677
Ensembl chr 7:105,532,169...105,567,677
|
|
G |
G |
SCO1 |
SCO1, cytochrome c oxidase assembly protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chr16:10,021,480...10,036,920
|
|
G |
P |
SCO1 |
synthesis of cytochrome C oxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chr12:55,406,730...55,424,120
Ensembl chr12:55,405,483...55,424,118
|
|
G |
D |
SCO1 |
synthesis of cytochrome C oxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chr 5:34,957,358...34,971,684
Ensembl chr 5:34,957,785...34,971,661
|
|
G |
R |
Sco1 |
synthesis of cytochrome C oxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chr10:51,744,656...51,757,246
Ensembl chr10:51,744,656...51,757,237
|
|
G |
M |
Sco1 |
SCO1 cytochrome c oxidase assembly protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chr11:66,943,473...66,958,270
Ensembl chr11:66,943,496...66,957,896
|
|
G |
H |
SCO1 |
synthesis of cytochrome C oxidase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20864674 |
|
NCBI chr17:10,672,474...10,697,533
Ensembl chr17:10,672,474...10,698,375
|
|
G |
N |
Serpinc1 |
serpin family C member 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:4089794 PMID:22563168 |
RGD:11035263 |
NCBI chrNW_004624771:7,955,778...7,966,637
Ensembl chrNW_004624771:7,955,739...7,966,637
|
|
G |
G |
SERPINC1 |
serpin family C member 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:4089794 PMID:22563168 |
RGD:11035263 |
NCBI chr25:55,271,823...55,289,855
|
|
G |
P |
SERPINC1 |
serpin family C member 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:4089794 PMID:22563168 |
RGD:11035263 |
NCBI chr 9:116,181,988...116,193,100
Ensembl chr 9:116,181,670...116,193,201
|
|
G |
S |
Serpinc1 |
serpin family C member 1 |
treatment |
| |